Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus

Mai Fujita, Sumiko Shiota, Teruo Kuroda, Tsutomu Hatano, Takashi Yoshida, Tohru Mizushima, Tomofusa Tsuchiya

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

During the screening of compounds that potentiate the effect of antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA), we found that an extract of thyme (Thymus vulgaris L) leaves greatly reduced the minimum inhibitory concentration (MIC) of tetracycline against MRSA. We isolated the effective compound and identified it as baicalein (5, 6, 7-trihydroxyflavone). One of the clinically isolated MRSA strains possessed tetK, a gene encoding active efflux pump for tetracycline. We examined the effect of baicalein on the efflux of tetracycline, using Escherichia coli KAM32/pTZ1252 carrying the tetK. The E. coli KAM32/pTZ1252 showed 8 to 16 times higher MIC than E. coli KAM32. We observed strong inhibition of transport of tetracycline by baicalein with membrane vesicles prepared from E. coli KAM32/pTZ1252. Baicalein also showed synergy with tetracycline in a MRSA strain that doesn't possess tetK, or with β-lactams. Thus, mechanisms of the synergies seem to be versatile.

Original languageEnglish
Pages (from-to)391-396
Number of pages6
JournalMicrobiology and Immunology
Volume49
Issue number4
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Lactams
Methicillin-Resistant Staphylococcus aureus
Tetracycline
Thymus Plant
Escherichia coli
Microbial Sensitivity Tests
Anti-Infective Agents
baicalein
Membranes
Genes

Keywords

  • Baicalein
  • Inhibition of TetK
  • MRSA
  • Tetracycline

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Microbiology

Cite this

Fujita, M., Shiota, S., Kuroda, T., Hatano, T., Yoshida, T., Mizushima, T., & Tsuchiya, T. (2005). Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus. Microbiology and Immunology, 49(4), 391-396.

Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus. / Fujita, Mai; Shiota, Sumiko; Kuroda, Teruo; Hatano, Tsutomu; Yoshida, Takashi; Mizushima, Tohru; Tsuchiya, Tomofusa.

In: Microbiology and Immunology, Vol. 49, No. 4, 2005, p. 391-396.

Research output: Contribution to journalArticle

Fujita, M, Shiota, S, Kuroda, T, Hatano, T, Yoshida, T, Mizushima, T & Tsuchiya, T 2005, 'Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus', Microbiology and Immunology, vol. 49, no. 4, pp. 391-396.
Fujita, Mai ; Shiota, Sumiko ; Kuroda, Teruo ; Hatano, Tsutomu ; Yoshida, Takashi ; Mizushima, Tohru ; Tsuchiya, Tomofusa. / Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus. In: Microbiology and Immunology. 2005 ; Vol. 49, No. 4. pp. 391-396.
@article{efada4adf74540ffba310b842270b0b6,
title = "Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus",
abstract = "During the screening of compounds that potentiate the effect of antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA), we found that an extract of thyme (Thymus vulgaris L) leaves greatly reduced the minimum inhibitory concentration (MIC) of tetracycline against MRSA. We isolated the effective compound and identified it as baicalein (5, 6, 7-trihydroxyflavone). One of the clinically isolated MRSA strains possessed tetK, a gene encoding active efflux pump for tetracycline. We examined the effect of baicalein on the efflux of tetracycline, using Escherichia coli KAM32/pTZ1252 carrying the tetK. The E. coli KAM32/pTZ1252 showed 8 to 16 times higher MIC than E. coli KAM32. We observed strong inhibition of transport of tetracycline by baicalein with membrane vesicles prepared from E. coli KAM32/pTZ1252. Baicalein also showed synergy with tetracycline in a MRSA strain that doesn't possess tetK, or with β-lactams. Thus, mechanisms of the synergies seem to be versatile.",
keywords = "Baicalein, Inhibition of TetK, MRSA, Tetracycline",
author = "Mai Fujita and Sumiko Shiota and Teruo Kuroda and Tsutomu Hatano and Takashi Yoshida and Tohru Mizushima and Tomofusa Tsuchiya",
year = "2005",
language = "English",
volume = "49",
pages = "391--396",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "4",

}

TY - JOUR

T1 - Remarkable synergies between baicalein and tetracycline, and baicalein and β-lactams against methicillin-resistant Staphylococcus aureus

AU - Fujita, Mai

AU - Shiota, Sumiko

AU - Kuroda, Teruo

AU - Hatano, Tsutomu

AU - Yoshida, Takashi

AU - Mizushima, Tohru

AU - Tsuchiya, Tomofusa

PY - 2005

Y1 - 2005

N2 - During the screening of compounds that potentiate the effect of antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA), we found that an extract of thyme (Thymus vulgaris L) leaves greatly reduced the minimum inhibitory concentration (MIC) of tetracycline against MRSA. We isolated the effective compound and identified it as baicalein (5, 6, 7-trihydroxyflavone). One of the clinically isolated MRSA strains possessed tetK, a gene encoding active efflux pump for tetracycline. We examined the effect of baicalein on the efflux of tetracycline, using Escherichia coli KAM32/pTZ1252 carrying the tetK. The E. coli KAM32/pTZ1252 showed 8 to 16 times higher MIC than E. coli KAM32. We observed strong inhibition of transport of tetracycline by baicalein with membrane vesicles prepared from E. coli KAM32/pTZ1252. Baicalein also showed synergy with tetracycline in a MRSA strain that doesn't possess tetK, or with β-lactams. Thus, mechanisms of the synergies seem to be versatile.

AB - During the screening of compounds that potentiate the effect of antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA), we found that an extract of thyme (Thymus vulgaris L) leaves greatly reduced the minimum inhibitory concentration (MIC) of tetracycline against MRSA. We isolated the effective compound and identified it as baicalein (5, 6, 7-trihydroxyflavone). One of the clinically isolated MRSA strains possessed tetK, a gene encoding active efflux pump for tetracycline. We examined the effect of baicalein on the efflux of tetracycline, using Escherichia coli KAM32/pTZ1252 carrying the tetK. The E. coli KAM32/pTZ1252 showed 8 to 16 times higher MIC than E. coli KAM32. We observed strong inhibition of transport of tetracycline by baicalein with membrane vesicles prepared from E. coli KAM32/pTZ1252. Baicalein also showed synergy with tetracycline in a MRSA strain that doesn't possess tetK, or with β-lactams. Thus, mechanisms of the synergies seem to be versatile.

KW - Baicalein

KW - Inhibition of TetK

KW - MRSA

KW - Tetracycline

UR - http://www.scopus.com/inward/record.url?scp=18244409351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244409351&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 391

EP - 396

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 4

ER -